ProQR Therapeutics (PRQR) Revenue & Revenue Breakdown
ProQR Therapeutics Revenue Highlights
Latest Revenue (Y)
$6.38M
Latest Revenue (Q)
$4.48M
Main Segment (Y)
Up-front payments
ProQR Therapeutics Revenue by Period
ProQR Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $6.38M | 58.05% |
| 2022-12-31 | $4.04M | 198.15% |
| 2021-12-31 | $1.35M | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $1.93M | -60.88% |
| 2018-12-31 | $4.94M | -423.15% |
| 2017-12-31 | $-1.53M | -167.00% |
| 2016-12-31 | $2.28M | -75.74% |
| 2015-12-31 | $9.41M | 2905.43% |
| 2014-12-31 | $313.00K | 100.00% |
| 2013-12-31 | - | - |
ProQR Therapeutics generated $6.38M in revenue during NA 2023, up 58.05% compared to the previous quarter, and up 129.13% compared to the same period a year ago.
ProQR Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $4.48M | 39.89% |
| 2023-12-31 | $3.20M | 133.56% |
| 2023-09-30 | $1.37M | 13.69% |
| 2023-06-30 | $1.21M | 83.97% |
| 2023-03-31 | $655.00K | -20.32% |
| 2022-12-31 | $822.00K | -14.02% |
| 2022-09-30 | $956.00K | -6.73% |
| 2022-06-30 | $1.02M | -16.94% |
| 2022-03-31 | $1.23M | 416.32% |
| 2021-12-31 | $239.00K | -72.59% |
| 2021-09-30 | $872.00K | 258.85% |
| 2021-06-30 | $243.00K | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $1.93M | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $4.94M | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-12-31 | $-1.53M | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | -100.00% |
| 2016-12-31 | $2.28M | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | -100.00% |
| 2014-12-31 | $309.00K | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | - |
ProQR Therapeutics generated $4.48M in revenue during Q1 2024, up 39.89% compared to the previous quarter, and up 544.55% compared to the same period a year ago.
ProQR Therapeutics Revenue Breakdown
ProQR Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Up-front payments | $6.00M | $191.00K | $252.00K |
| R&D services | - | $118.00K | $282.00K |
| Premiums on share issue | - | $48.00K | $168.00K |
ProQR Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Up-front payments (100.00%).
ProQR Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals | $1.83B | $659.83M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| BPMC | Blueprint Medicines | $249.38M | $138.16M |
| ARWR | Arrowhead Pharmaceuticals | $240.74M | - |
| WVE | Wave Life Sciences | $113.31M | $19.69M |
| CTMX | CytomX Therapeutics | $101.21M | $25.11M |
| SPRO | Spero Therapeutics | $96.73M | $10.20M |
| ASMB | Assembly Biosciences | $7.16M | $5.79M |
| PRQR | ProQR Therapeutics | $6.38M | $4.48M |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| NXTC | NextCure | - | - |
| TIL | Instil Bio | - | - |
| ANNX | Annexon | - | - |
| NLTX | Neurogene | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ACHL | Achilles Therapeutics | - | - |
| NUVB | Nuvation Bio | - | $1.44M |
PRQR Revenue FAQ
What is ProQR Therapeutics’s yearly revenue?
ProQR Therapeutics's yearly revenue for 2023 was $6.38M, representing an increase of 58.05% compared to 2022. The company's yearly revenue for 2022 was $4.04M, representing an increase of 198.15% compared to 2021. PRQR's yearly revenue for 2021 was $1.35M, representing an increase of 100.00% compared to 2020.
What is ProQR Therapeutics’s quarterly revenue?
ProQR Therapeutics's quarterly revenue for Q1 2024 was $4.48M, a 39.89% increase from the previous quarter (Q4 2023), and a 583.39% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $3.2M, a 133.56% increase from the previous quarter (Q3 2023), and a 289.26% increase year-over-year (Q4 2022). PRQR's quarterly revenue for Q3 2023 was $1.37M, a 13.69% increase from the previous quarter (Q2 2023), and a 43.31% increase year-over-year (Q3 2022).
What is ProQR Therapeutics’s revenue growth rate?
ProQR Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 371.23%, and for the last 5 years (2019-2023) was 230.08%.
What are ProQR Therapeutics’s revenue streams?
ProQR Therapeutics's revenue streams in c 23 are Up-front payments
What is ProQR Therapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of ProQR Therapeutics was Up-front payments. This segment made a revenue of $6M, representing 100.00% of the company's total revenue.